{"entity":{"type":"insider","cik":"0001647664","url":"/insider/0001647664","json_url":"/insider/0001647664.json","name":"You Angie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2017-03-09","last":"2025-06-23","span_basis":"filed_date"},"name_variants":[{"name":"You Angie","source":"filing","n_filings":2,"first_seen":"2017-03-09","last_seen":"2025-06-23"}],"transactions":[{"id":4383009,"accession":"0001415889-25-018014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-018014","line_url":"/filing/0001415889-25-018014#line-2","is_derivative":false,"issuer_cik":"0001647664","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001647664","owner_cik":"0001647664","owner_name":"You Angie","owner_url":"/insider/0001647664","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1403.0,"shares_display":"1,403","price_per_share":9.43,"price_display":"9.43","price_state":"stated","total_value":13230.29,"total_display":"13,230.29","shares_owned_after":28000.0,"shares_owned_after_display":"28,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-23","filed_date":"2025-06-23","scope":"insider"},{"id":4383002,"accession":"0001415889-25-018014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-018014","line_url":"/filing/0001415889-25-018014#line-1","is_derivative":false,"issuer_cik":"0001647664","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001647664","owner_cik":"0001647664","owner_name":"You Angie","owner_url":"/insider/0001647664","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26597.0,"shares_display":"26,597","price_per_share":9.3871,"price_display":"9.39","price_state":"stated","total_value":249668.6987,"total_display":"249,668.70","shares_owned_after":26597.0,"shares_owned_after_display":"26,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-23","scope":"insider"},{"id":4413759,"accession":"0001209191-17-019696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-019696","line_url":"/filing/0001209191-17-019696#line-1","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001647664","owner_name":"You Angie","owner_url":"/insider/0001647664","role":"Officer (Chief Bus. & Strat. Officer)","officer_title":"Chief Bus. & Strat. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":42900.0,"total_display":"42,900.00","shares_owned_after":133252.0,"shares_owned_after_display":"133,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-08","filed_date":"2017-03-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001796280","name":"Oric Pharmaceuticals, Inc.","url":"/issuer/0001796280","role":"Director","n_filings":1,"first_seen":"2025-06-23","last_seen":"2025-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Officer (Chief Bus. & Strat. Officer)","n_filings":1,"first_seen":"2017-03-09","last_seen":"2017-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001647664","retrieved_at":"2026-08-22T04:02:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}